Isomorphic Labs

The company utilizes machine learning and generative AI models to model complex biological phenomena and design novel molecules. By building upon the AlphaFold system, it develops a drug design engine to predict drug performance and accelerate the discovery of medicines for devastating diseases. The firm collaborates with pharmaceutical partners like Johnson & Johnson to transform the traditional drug discovery process through digital biology.